Gil Aharon bought NRXS once, on Dec 23, 2025

Dr. Gilad Aharon (also referred to as Aharon Gil), age 51, is an independent director at NeurAxis, Inc. (NRXS), appointed on November 19, 2024, effective January 1, 2025. He chairs the Compensation Committee and serves on the Board, determined to be independent under SEC and NYSE American rules.(

Dr. Aharon co-founded Rosalind Advisors, Inc. and has been a Portfolio Manager there since 2006, with prior experience as an Equity Analyst at Infinium Securities Inc. He holds a Ph.D. in Biophysics and Molecular Biology from the University of Toronto, bringing expertise in scientific analysis and capital markets to his role. Recently, on December 23, 2025, he reported an indirect purchase of 286,138 NRXS common shares at $3.52 each through Rosalind Master Fund L.P., valued at approximately $1,007,205, disclaiming beneficial ownership except to his pecuniary interest.( He has indirect ownership linkage to the fund, which holds significant Series B Preferred shares in NRXS.(

Written by Perplexity from public sources.